Zometa: Osteoporosis Drug Doesn’t Work for Breast Cancer
Zometa was designed as an osteoporosis drug, and the exclusive rights to manufacture it was almost over - the patent was expiring.
Zometa is expensive for the patient, and profitable for
Dr. Martin McIntosh DC